About 30% of top-performing OTC drugs today were once prescription-only medications noted Dave Wendland, VP Hamacher Resource Group, on Thursday during a videocast hosted by GMDC titled "Rx-to-OTC: Getting it Right at Retail."
Hamacher Resource Group on Monday announced that Dave Wendland, Hamacher VP, will present "Rx-to-OTC: Getting It Right at Retail," an educational videocast for retailers sponsored by the Global Market Development Center on Thursday, July 17.
As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.
Nearly 8,000 attendees will converge in Washington, D.C., in July for Cardinal Health’s annual Retail Business Conference, which provides independent pharmacists and pharmacy franchise owners an opportunity to network with and learn from peers, as well as gain new insights into improving business effectiveness and efficiency.
Gain detergent, a brand from Procter & Gamble, announced that it will give attendees of this year's Essence Festival a scent-filled experience with Gain flings! "Music to Your Nose," which will take place inside P&G's My Black is Beautiful booth at the Ernest N. Morial Convention Center.
According to a new study, 9-out-of-10 consumers prefer to be in control of medical decisions or participate in shared decision-making with their doctors. Evidence, however, suggests that the cost of care does not typically play a part in these discussions.
Women today play a dynamic role in society, and brands and marketers — including those within the retail pharmacy space — are tirelessly working to earn her trust and loyalty, as she often makes most of the healthcare decisions for her family. While reaching “moms” is no doubt important, new research suggests that brands and marketers may be missing a tremendous opportunity among those women who are rewriting the fairy tale. Enter “Otherhood.”
Capitol Hill staffers this week learned useful tips from a medical expert on reading and understanding dietary supplement labels, and received a primer on the depth of regulation behind dietary supplement labeling during an educational briefing held by the Congressional Dietary Supplement Caucus in cooperation with the leading trade associations representing the dietary supplement industry, the group announced Friday.
In an article published Wednesday in the Health Affairs blog, CVS Caremark chief medical and scientific officers and others commented on a missing piece in the current approach to accountable healthcare models.
America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.
Merck announced on Friday that it is commencing, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals. On June 9, Merck announced its intent to acquire Idenix.
The American Diabetes Association will lower its target recommendation for blood glucose levels for children with Type 1 diabetes, according to a statement released at the association's 74th Scientific Sessions.